Hung-Hsin Chen

Hung-Hsin Chen

Auto-generated profile, based on publicly available information

Hung-Hsin Chen

Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2015 in International Journal of Obesity
Verified
Journal Article
Closed access
HCH-H Chen
H-H Chen
YTYufeng Jane Tseng
Yufeng Jane Tseng
SWS-Y Wang
S-Y Wang
YTY-S Tsai
Y-S Tsai
CCC-S Chang
C-S Chang
PKPo-Hsiu Kuo
Po-Hsiu Kuo

4 December 2023 in Nature
Verified
Journal Article
Closed access
PDF file
JWJohn T. Walker
John T. Walker
DSDiane C. Saunders
Diane C. Saunders
VRVivek Rai
Vivek Rai
HCHung-Hsin Chen
Hung-Hsin Chen
POPeter Orchard
Peter Orchard
MBMarcela Brissova
Marcela Brissova

15 October 2025 in Nature
Verified
Journal Article
Open access
PDF file
HYHsin-Chou Yang
Hsin-Chou Yang
PKPui-Yan Kwok
Pui-Yan Kwok
LLLing-Hui Li
Ling-Hui Li
YLYi-Min Liu
Yi-Min Liu
YJYuh-Jyh Jong
Yuh-Jyh Jong
JWJer-Yuarn Wu
Jer-Yuarn Wu
Han Chinese people comprise nearly 20% of the global population but remain under-represented in genetic studies 1,2 , so there is an urgent need for large-scale cohorts to advance precision medicine. Here we present the Taiwan Precision Medicine Initiative (TPMI), established by Academia Sinica in collaboration with 16 major medical centres around Taiwan, which has recruited 565,390 participants who consent to provide DNA samples for genetic profiling and grant access to their electronic medical records (EMRs) for research. EMR access is both retrospective and prospective, allowing longitudinal studies. Genetic profiling is done with population-optimized arrays of single-nucleotide polymorphisms for people of Han Chinese ancestry, which enable genome-wide association 3,4 , phenome-wide association 5,6 and polygenic risk score 7,8 studies to be performed to evaluate common disease risk and pharmacogenetic response. Participants also agreed to be re-contacted for future research and receive personalized genetic risk profiles with health management recommendations. The TPMI has established the TPMI Data Access Platform, a central database and analysis platform that both safeguards the security of the data and facilitates academic research. As a large cohort of individuals with non-European ancestry that merges genetic profiles with EMR data and enables longitudinal follow-up, TPMI provides a unique resource that could be used to validate genetic risk prediction models, perform clinical trials of risk-based health management and inform health policies. Ultimately, the TPMI cohort will contribute to global genetic research and serve as a model for population-based precision medicine.

15 October 2025 in Nature
Verified
Journal Article
Open access
PDF file
HCHung-Hsin Chen
Hung-Hsin Chen
CCChien-Hsiun Chen
Chien-Hsiun Chen
MHMing-Chih Hou
Ming-Chih Hou
YFYun-Ching Fu
Yun-Ching Fu
LLLing-Hui Li
Ling-Hui Li
CFCathy S J Fann
Cathy S J Fann
Predicting complex disease risks on the basis of individual genomic profiles is an advancing field in human genetics1,2. However, most genetic studies have focused on populations of European ancestry, creating a global imbalance in precision medicine and underscoring the need for genomic research in non-European groups3,4. The Taiwan Precision Medicine Initiative recruited more than half a million Taiwanese residents, providing a large dataset of genetic profiles and electronic medical record data for people with Han Chinese ancestry. Using extensive phenotypic data, we conducted comprehensive genomic analyses across the medical phenome with individuals genetically similar to Han Chinese reference populations. These analyses identified population-specific genetic risk variants and new findings for various complex traits. We developed polygenic risk scores, demonstrating strong predictive performance for conditions such as cardiometabolic diseases, autoimmune disorders, cancers and infectious diseases. We observed consistent findings in an independent dataset, Taiwan Biobank, and among people of East Asian ancestry in the UK Biobank and the All of Us Project. The identified genetic risks accounted for up to 10.3% of the overall health variation in the Taiwan Precision Medicine Initiative cohort. Our approach of characterizing the phenome-wide genomic landscape, developing population-specific risk-prediction models, assessing their performance and identifying the genetic effect on health serves as a model for similar studies in other diverse study populations.

6 December 2021 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
HCHung-Hsin Chen
Hung-Hsin Chen
LPLauren E. Petty
Lauren E. Petty
JSJin Sha
Jin Sha
YZYi Zhao
Yi Zhao
AKAmanda Kuzma
Amanda Kuzma
JBJennifer E. Below
Jennifer E. Below
Late-onset Alzheimer disease (LOAD) is highly polygenic, with a heritability estimated between 40 and 80%, yet risk variants identified in genome-wide studies explain only ~8% of phenotypic variance. Due to its increased power and interpretability, genetically regulated expression (GReX) analysis is an emerging approach to investigate the genetic mechanisms of complex diseases. Here, we conducted GReX analysis within and across 51 tissues on 39 LOAD GWAS data sets comprising 58,713 cases and controls from the Alzheimer’s Disease Genetics Consortium (ADGC) and the International Genomics of Alzheimer’s Project (IGAP). Meta-analysis across studies identified 216 unique significant genes, including 72 with no previously reported LOAD GWAS associations. Cross-brain-tissue and cross-GTEx models revealed eight additional genes significantly associated with LOAD. Conditional analysis of previously reported loci using established LOAD-risk variants identified eight genes reaching genome-wide significance independent of known signals. Moreover, the proportion of SNP-based heritability is highly enriched in genes identified by GReX analysis. In summary, GReX-based meta-analysis in LOAD identifies 216 genes (including 72 novel genes), illuminating the role of gene regulatory models in LOAD.

28 December 2017 in Oncotarget
Verified
Journal Article
Open access
HLHsin-Chen Lin
Hsin-Chen Lin
CYChing-Ching Yeh
Ching-Ching Yeh
LCLo-Yun Chao
Lo-Yun Chao
MTMong-Hsun Tsai
Mong-Hsun Tsai
HCHung-Hsin Chen
Hung-Hsin Chen
LLLiang-Chuan Lai
Liang-Chuan Lai
The hypoxia-responsive lncRNA NDRG-OT1 promotes NDRG1 degradation via ubiquitin-mediated proteolysis in breast cancer cells The hypoxia-responsive lncRNA NDRG-OT1 promotes NDRG1 degradation via ubiquitin-mediated proteolysis in breast cancer cells